Open AccessImprovement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder
Author(s) -
Tanya J. Fabian,
Zachary Cain,
Diane Ammerman,
James M. Eudicone,
Yan Tang,
Linda M. Rollin,
Robert A. Forbes,
Robert Berman,
Ross A. Baker
Publication year - 2012
Publication title -
the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.12m01394
Subject(s) - aripiprazole , placebo , medicine , major depressive disorder , post hoc analysis , antidepressant , adjunctive treatment , psychology , psychiatry , schizophrenia (object oriented programming) , alternative medicine , pathology , amygdala , hippocampus
To evaluate the effect of adjunctive aripiprazole to antidepressant therapy (ADT) on functional outcomes, as assessed by the Sheehan Disability Scale (SDS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom